Jack Sargent
0000-0003-2786-5525
1 paper found
Refreshing results…
A randomized, open‐label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes
Missing publications? Search for publications with a matching author name.